First-Line Bladder Cancer Trial Makes the Case for HER2 Screening

(MedPage Today) — BERLIN — A Chinese trial that screened advanced urothelial cancer patients for HER2-expression demonstrated a large survival benefit with a novel chemotherapy-free combination in the first-line setting, though it’s unclear…